Citations (72)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Xiwen Wang & Jungang Zhao. (2022) Targeted Cancer Therapy Based on Acetylation and Deacetylation of Key Proteins Involved in Double-Strand Break Repair. Cancer Management and Research 14, pages 259-271.
Read now
Read now
Insa Schiffmann, Gabriele Greve, Manfred Jung & Michael Lübbert. (2016) Epigenetic therapy approaches in non-small cell lung cancer: Update and perspectives. Epigenetics 11:12, pages 858-870.
Read now
Read now
Ronald Allan M. Panganiban, Ognoon Mungunsukh & Regina M. Day. (2013) X-irradiation induces ER stress, apoptosis, and senescence in pulmonary artery endothelial cells. International Journal of Radiation Biology 89:8, pages 656-667.
Read now
Read now
Articles from other publishers (69)
Terezia Vcelkova, Wolfgang Reiter, Martha Zylka, David M Hollenstein, Stefan Schuckert, Markus Hartl & Christian Seiser. (2023) GSE1 links the HDAC1/CoREST co-repressor complex to DNA damage. Nucleic Acids Research 51:21, pages 11748-11769.
Crossref
Crossref
Costanza Lo Cascio, Tigran Margaryan, Ernesto Luna-Melendez, James B. McNamara, Connor I. White, William Knight, Saisrinidhi Ganta, Zorana Opachich, Claudia Cantoni, Wonsuk Yoo, Nader Sanai, Artak Tovmasyan & Shwetal Mehta. (2023) Quisinostat is a brain-penetrant radiosensitizer in glioblastoma. JCI Insight 8:22.
Crossref
Crossref
Rui Ling, Jingzhi Wang, Yuan Fang, Yunpeng Yu, Yuting Su, Wen Sun, Xiaoqin Li & Xiang Tang. (2023) HDAC-an important target for improving tumor radiotherapy resistance. Frontiers in Oncology 13.
Crossref
Crossref
Lina Alhaddad, Andreyan N. Osipov & Sergey Leonov. (2022) The Molecular and Cellular Strategies of Glioblastoma and Non-Small-Cell Lung Cancer Cells Conferring Radioresistance. International Journal of Molecular Sciences 23:21, pages 13577.
Crossref
Crossref
Abdelhakim Bouyahya, Nasreddine El Omari, Mohamed Bakha, Tarik Aanniz, Naoual El Menyiy, Naoufal El Hachlafi, Aicha El Baaboua, Mohamed El-Shazly, Mohammed Merae Alshahrani, Ahmed Abdullah Al Awadh, Learn-Han Lee, Taoufiq Benali & Mohammad S. Mubarak. (2022) Pharmacological Properties of Trichostatin A, Focusing on the Anticancer Potential: A Comprehensive Review. Pharmaceuticals 15:10, pages 1235.
Crossref
Crossref
María Ovejero-Sánchez, Jorge Rubio-Heras, María del Carmen Vicente de la Peña, Laura San-Segundo, Jesús Pérez-Losada, Rogelio González-Sarmiento & Ana Belén Herrero. (2022) Chloroquine-Induced DNA Damage Synergizes with Nonhomologous End Joining Inhibition to Cause Ovarian Cancer Cell Cytotoxicity. International Journal of Molecular Sciences 23:14, pages 7518.
Crossref
Crossref
Nannan Guo, Shaojun Li, Bo Liu, Ping Chen, Jingbo Li, Yunlong Zhao, Yingnan Zhao, Jian Tang & Wen Zhang. (2022) Inhibiting nonhomologous end-joining repair would promote the antitumor activity of gemcitabine in nonsmall cell lung cancer cell lines. Anti-Cancer Drugs 33:5, pages 502-508.
Crossref
Crossref
Olga O. Gnedina, Alisa V. Morshneva, Elena V. Skvortsova & Maria V. Igotti. (2022) HDAC Inhibitor Sodium Butyrate Attenuates the DNA Repair in Transformed but Not in Normal Fibroblasts. International Journal of Molecular Sciences 23:7, pages 3517.
Crossref
Crossref
Katsuhiko Minami, Shiori Iida & Kazuhiro Maeshima. 2022. DNA Damage and Double Strand Breaks - Part A. DNA Damage and Double Strand Breaks - Part A
29
51
.
Mansi K. Aparnathi, Sami Ul Haq, Zishan Allibhai, Benjamin H. Lok & Anthony M. Brade. 2023. Advances in Radiation Oncology in Lung Cancer. Advances in Radiation Oncology in Lung Cancer
285
302
.
Hong Li, Liying Ma, Xing Bian, Yang Lv & Wenchu Lin. (2021) FK228 sensitizes radioresistant small cell lung cancer cells to radiation. Clinical Epigenetics 13:1.
Crossref
Crossref
Hari Krishna Namballa, Pratibha Anchi, Kesari Lakshmi Manasa, Jay Prakash Soni, Chandraiah Godugu, Nagula Shankaraiah & Ahmed Kamal. (2021) β-Carboline tethered cinnamoyl 2-aminobenzamides as class I selective HDAC inhibitors: Design, synthesis, biological activities and modelling studies. Bioorganic Chemistry 117, pages 105461.
Crossref
Crossref
Khuloud Bajbouj, Abeer Al-Ali, Rakhee K. Ramakrishnan, Maha Saber-Ayad & Qutayba Hamid. (2021) Histone Modification in NSCLC: Molecular Mechanisms and Therapeutic Targets. International Journal of Molecular Sciences 22:21, pages 11701.
Crossref
Crossref
Fengqiu Zhang, Changsheng Shao, Zhu Chen, Yalin Li, Xumiao Jing & Qing Huang. (2021) Low Dose of Trichostatin A Improves Radiation Resistance by Activating Akt/Nrf2-Dependent Antioxidation Pathway in Cancer Cells. Radiation Research 195:4.
Crossref
Crossref
Gesche Tallen, Yang Yang & Karl Riabowol. 2021. Genome Stability. Genome Stability
521
531
.
Meera Venkatesh & Shyam Shrivastava. 2021. Encyclopedia of Nuclear Energy. Encyclopedia of Nuclear Energy
280
289
.
Ekta Shirbhate, Preeti Patel, Vijay K Patel, Ravichandran Veerasamy, Prabodh C Sharma & Harish Rajak. (2020) The combination of histone deacetylase inhibitors and radiotherapy: a promising novel approach for cancer treatment. Future Oncology 16:30, pages 2457-2469.
Crossref
Crossref
Radoslav Aleksandrov, Rossitsa Hristova, Stoyno Stoynov & Anastas Gospodinov. (2020) The Chromatin Response to Double-Strand DNA Breaks and Their Repair. Cells 9:8, pages 1853.
Crossref
Crossref
Giorgio Milazzo, Daniele Mercatelli, Giulia Di Muzio, Luca Triboli, Piergiuseppe De Rosa, Giovanni Perini & Federico M. Giorgi. (2020) Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability. Genes 11:5, pages 556.
Crossref
Crossref
Nóra Igaz, Krisztina Szőke, Dávid Kovács, Andrea Buhala, Zoltán Varga, Péter Bélteky, Zsolt Rázga, László Tiszlavicz, Csaba Vizler, Katalin Hideghéty, Zoltán Kónya & Mónika Kiricsi. (2020) Synergistic Radiosensitization by Gold Nanoparticles and the Histone Deacetylase Inhibitor SAHA in 2D and 3D Cancer Cell Cultures. Nanomaterials 10:1, pages 158.
Crossref
Crossref
Faria Sultana, Kesari Lakshmi Manasa, Siddiq Pasha Shaik, Srinivasa Reddy Bonam & Ahmed Kamal. (2020) Zinc Dependent Histone Deacetylase Inhibitors in Cancer Therapeutics: Recent Update. Current Medicinal Chemistry 26:40, pages 7212-7280.
Crossref
Crossref
Alanna R. Kaplan & Peter M. Glazer. 2020.
187
213
.
Vazhappilly Cijo George, Shabbir Ahmed Ansari, Vipin Shankar Chelakkot, Ayshwarya Lakshmi Chelakkot, Chaithanya Chelakkot, Varsha Menon, Wafaa Ramadan, Kannatt Radhakrishnan Ethiraj, Raafat El-Awady, Theodora Mantso, Melina Mitsiogianni, Mihalis I. Panagiotidis, Graham Dellaire & H.P. Vasantha Rupasinghe. (2019) DNA-dependent protein kinase: Epigenetic alterations and the role in genomic stability of cancer. Mutation Research/Reviews in Mutation Research 780, pages 92-105.
Crossref
Crossref
Markus Christmann & Bernd Kaina. (2019) Epigenetic regulation of DNA repair genes and implications for tumor therapy. Mutation Research/Reviews in Mutation Research 780, pages 15-28.
Crossref
Crossref
Ning Ding, Ashley R. Maiuri & Heather M. O’Hagan. (2019) The emerging role of epigenetic modifiers in repair of DNA damage associated with chronic inflammatory diseases. Mutation Research/Reviews in Mutation Research 780, pages 69-81.
Crossref
Crossref
Fengqiu Zhang, Zhu Chen, Changsheng Shao & Qing Huang. (2019) Is level of acetylation directly correlated to radiation sensitivity of cancer cell?. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 813, pages 13-19.
Crossref
Crossref
Sarah L. Kerns, Kuang-Hsiang Chuang, William Hall, Zachary Werner, Yuhchyau Chen, Harry Ostrer, Catharine West & Barry Rosenstein. (2018) Radiation biology and oncology in the genomic era. The British Journal of Radiology 91:1091, pages 20170949.
Crossref
Crossref
Yu Ran Lee, Myoung Soo Park, Hee Kyoung Joo, Ki Mo Kim, Jeryong Kim, Byeong Hwa Jeon & Sunga Choi. (2018) Therapeutic positioning of secretory acetylated APE1/Ref-1 requirement for suppression of tumor growth in triple-negative breast cancer in vivo. Scientific Reports 8:1.
Crossref
Crossref
Nilsa Rivera-Del Valle, Tiewei Cheng, Mary E. Irwin, Hayley Donnella, Melissa M. Singh & Joya Chandra. (2018) Combinatorial effects of histone deacetylase inhibitors (HDACi), vorinostat and entinostat, and adaphostin are characterized by distinct redox alterations. Cancer Chemotherapy and Pharmacology 81:3, pages 483-495.
Crossref
Crossref
Mina Eriksson, Petra Hååg, Beata Brzozowska, Magdalena Lipka, Halina Lisowska, Rolf Lewensohn, Andrzej Wojcik, Kristina Viktorsson & Lovisa Lundholm. (2018) Analysis of Chromatin Opening in Heterochromatic Non-Small Cell Lung Cancer Tumor-Initiating Cells in Relation to DNA-Damaging Antitumor Treatment. International Journal of Radiation Oncology*Biology*Physics 100:1, pages 174-187.
Crossref
Crossref
Sofia Rivera, Céline Leteur, Frédérique Mégnin, Frédéric Law, Isabelle Martins, Ioana Kloos, Stéphane Depil, Nazanine Modjtahedi, Jean Luc Perfettini, Christophe Hennequin & Eric Deutsch. (2017) Time dependent modulation of tumor radiosensitivity by a pan HDAC inhibitor: abexinostat. Oncotarget 8:34, pages 56210-56227.
Crossref
Crossref
Sophia Mastoraki & Evi Lianidou. 2017. DNA and Histone Methylation as Cancer Targets. DNA and Histone Methylation as Cancer Targets
403
436
.
Lingfei Jia, Shan Zhang, Yiping Huang, Yunfei Zheng & Yehua Gan. (2016) Trichostatin A increases radiosensitization of tongue squamous cell carcinoma via miR‑375. Oncology Reports.
Crossref
Crossref
Jin Meng, Xu-Tao Zhang, Xin-Li Liu, Lei Fan, Chen Li, Yang Sun, Xiao-Hua Liang, Jian-Bo Wang, Qi-Bing Mei, Feng Zhang & Tao Zhang. (2016) WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways. Cellular Signalling 28:11, pages 1673-1682.
Crossref
Crossref
Wynand Paul Roos & Andrea Krumm. (2016) The multifaceted influence of histone deacetylases on DNA damage signalling and DNA repair. Nucleic Acids Research, pages gkw922.
Crossref
Crossref
Antonello Di Paolo, Marzia Del Re, Iacopo Petrini, Giuseppe Altavilla & Romano Danesi. (2016) Recent advances in epigenomics in NSCLC: real-time detection and therapeutic implications. Epigenomics 8:8, pages 1151-1167.
Crossref
Crossref
Ralph Pietrofesa, Anastasia Velalopoulou, Stacey Lehman, Evguenia Arguiri, Pantelis Solomides, Cameron Koch, Om Mishra, Constantinos Koumenis, Thomas Goodwin & Melpo Christofidou-Solomidou. (2016) Novel Double-Hit Model of Radiation and Hyperoxia-Induced Oxidative Cell Damage Relevant to Space Travel. International Journal of Molecular Sciences 17:6, pages 953.
Crossref
Crossref
Carine Robert, Pratik K. Nagaria, Nisha Pawar, Adeoluwa Adewuyi, Ivana Gojo, David J. Meyers, Philip A. Cole & Feyruz V. Rassool. (2016) Histone deacetylase inhibitors decrease NHEJ both by acetylation of repair factors and trapping of PARP1 at DNA double-strand breaks in chromatin. Leukemia Research 45, pages 14-23.
Crossref
Crossref
Ching-Yu Yen, Hurng-Wern Huang, Chih-Wen Shu, Ming-Feng Hou, Shyng-Shiou F. Yuan, Hui-Ru Wang, Yung-Ting Chang, Ammad Ahmad Farooqi, Jen-Yang Tang & Hsueh-Wei Chang. (2016) DNA methylation, histone acetylation and methylation of epigenetic modifications as a therapeutic approach for cancers. Cancer Letters 373:2, pages 185-192.
Crossref
Crossref
Agnieszka Żuryń, Anna Litwiniec, Barbara Safiejko-Mroczka, Anna Klimaszewska-Wiśniewska, Maciej Gagat, Adrian Krajewski, Lidia Gackowska & Dariusz Grzanka. (2016) The effect of sulforaphane on the cell cycle, apoptosis and expression of cyclin D1 and p21 in the A549 non-small cell lung cancer cell line. International Journal of Oncology.
Crossref
Crossref
Yue Luo, Hui Wang, Xipeng Zhao, Chao Dong, Fengmei Zhang, Gang Guo, Gongshe Guo, Xiaowei Wang, Simon N. Powell & Zhihui Feng. (2016) Valproic acid causes radiosensitivity of breast cancer cells via disrupting the DNA repair pathway. Toxicology Research 5:3, pages 859-870.
Crossref
Crossref
Alice Pasini, Angelo Delmonte, Anna Tesei, Daniele Calistri & Emanuele Giordano. (2015) Targeting Chromatin-Mediated Transcriptional Control of Gene Expression in Non-Small Cell Lung Cancer Therapy: Preclinical Rationale and Clinical Results. Drugs 75:15, pages 1757-1771.
Crossref
Crossref
Lucheng Zhu, Kan Wu, Shenglin Ma & Shirong Zhang. (2015) HDAC Inhibitors: A New Radiosensitizer for Non-small-cell Lung Cancer. Tumori Journal 101:3, pages 257-262.
Crossref
Crossref
Yongguo Shi, Yangchen Liu, Jirong Wang, Ding Jie, Tian Yun, Wang Li, Lin Yan, Keming Wang & Jifeng Feng. (2015) Downregulated Long Noncoding RNA BANCR Promotes the Proliferation of Colorectal Cancer Cells via Downregualtion of p21 Expression. PLOS ONE 10:4, pages e0122679.
Crossref
Crossref
Chuan Liu, Hongyu Ding, Xiaoxi Li, Christian P Pallasch, Liya Hong, Dianwu Guo, Yi Chen, Difei Wang, Wei Wang, Yajie Wang, Michael T Hemann & Hai Jiang. (2015)
A
DNA
/
HDAC
dual‐targeting drug
CY
190602 with significantly enhanced anticancer potency
. EMBO Molecular Medicine 7:4, pages 438-449.
Crossref
Crossref
M M Olcina, S O'Dell & E M Hammond. (2015) Targeting chromatin to improve radiation response. The British Journal of Radiology 88:1047, pages 20140649.
Crossref
Crossref
Dineo Khabele. (2014) The Therapeutic Potential of Class I Selective Histone Deacetylase Inhibitors in Ovarian Cancer. Frontiers in Oncology 4.
Crossref
Crossref
Yunkyung Hong, Jinyoung Won, Youngjeon Lee, Seunghoon Lee, Kanghui Park, Kyu-Tae Chang & Yonggeun Hong. (2014) Melatonin treatment induces interplay of apoptosis, autophagy, and senescence in human colorectal cancer cells. Journal of Pineal Research 56:3, pages 264-274.
Crossref
Crossref
Qinghua Dong, Sherven Sharma, Hai Liu, Long Chen, Benxing Gu, Xiaonan Sun & Guanyu Wang. (2014) HDAC inhibitors reverse acquired radio resistance of KYSE-150R esophageal carcinoma cells by modulating Bmi-1 expression. Toxicology Letters 224:1, pages 121-129.
Crossref
Crossref
Deepika Dhawan, José A. Ramos-Vara, Noah M. Hahn, Jolena Waddell, Gayla R. Olbricht, Rong Zheng, Jane C. Stewart & Deborah W. Knapp. (2013) DNMT1: An emerging target in the treatment of invasive urinary bladder cancer. Urologic Oncology: Seminars and Original Investigations 31:8, pages 1761-1769.
Crossref
Crossref
Vasiliki Petta, Ioannis Gkiozos, Alex Strimpakos & Konstantinos Syrigos. (2013) Histones and lung cancer: are the histone deacetylases a promising therapeutic target?. Cancer Chemotherapy and Pharmacology 72:5, pages 935-952.
Crossref
Crossref
Hui-Wen Chiu, Ya-Ling Yeh, Yi-Ching Wang, Wei-Jan Huang, Yi-An Chen, Yi-Shiou Chiou, Sheng-Yow Ho, Pinpin Lin & Ying-Jan Wang. (2013) Suberoylanilide Hydroxamic Acid, an Inhibitor of Histone Deacetylase, Enhances Radiosensitivity and Suppresses Lung Metastasis in Breast Cancer In Vitro and In Vivo. PLoS ONE 8:10, pages e76340.
Crossref
Crossref
Hideaki Takata, Tomo Hanafusa, Toshiaki Mori, Mari Shimura, Yutaka Iida, Kenichi Ishikawa, Kenichi Yoshikawa, Yuko Yoshikawa & Kazuhiro Maeshima. (2013) Chromatin Compaction Protects Genomic DNA from Radiation Damage. PLoS ONE 8:10, pages e75622.
Crossref
Crossref
B Groselj, N L Sharma, F C Hamdy, M Kerr & A E Kiltie. (2013) Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair. British Journal of Cancer 108:4, pages 748-754.
Crossref
Crossref
Stanley L. LiauwPhilip P. ConnellRalph R. Weichselbaum. (2013) New Paradigms and Future Challenges in Radiation Oncology: An Update of Biological Targets and Technology. Science Translational Medicine 5:173.
Crossref
Crossref
Maria New, Heidi Olzscha & Nicholas B. La Thangue. (2012) HDAC inhibitor-based therapies: Can we interpret the code?. Molecular Oncology 6:6, pages 637-656.
Crossref
Crossref
Muktheshwar Gandesiri, Saritha Chakilam, Jelena Ivanovska, Natalya Benderska, Matthias Ocker, Pietro Di Fazio, Maria Feoktistova, Hala Gali-Muhtasib, Margret Rave-Fränk, Olaf Prante, Hans Christiansen, Martin Leverkus, Arndt Hartmann & Regine Schneider-Stock. (2012) DAPK plays an important role in panobinostat-induced autophagy and commits cells to apoptosis under autophagy deficient conditions. Apoptosis 17:12, pages 1300-1315.
Crossref
Crossref
Qinlan Ren, Jeremy Tey, Xiaoyu Li, Yu Wu, Hongbin Deng & Lan Han. (2012) Radiosensitization of cervical cancer xenografts by arsenic trioxide and the role of VEGF and Ku70. Journal of Radiation Oncology 1:3, pages 299-304.
Crossref
Crossref
Xufeng Chen, Patty Wong, Eric H. Radany, Jeremy M. Stark, Corentin Laulier & Jeffrey Y.C. Wong. (2012) Suberoylanilide Hydroxamic Acid as a Radiosensitizer through Modulation of RAD51 Protein and Inhibition of Homology-Directed Repair in Multiple Myeloma. Molecular Cancer Research 10:8, pages 1052-1064.
Crossref
Crossref
Carmela Dell'Aversana, Ilaria Lepore & Lucia Altucci. (2012) HDAC modulation and cell death in the clinic. Experimental Cell Research 318:11, pages 1229-1244.
Crossref
Crossref
Oronza Antonietta Botrugno, Thomas Robert, Fabio Vanoli, Marco Foiani & Saverio Minucci. (2012) Molecular Pathways: Old Drugs Define New Pathways: Non-Histone Acetylation at the Crossroads of the DNA Damage Response and Autophagy. Clinical Cancer Research 18:9, pages 2436-2442.
Crossref
Crossref
Bo Zhang, Yan Wang & Xueli Pang. (2010) Enhanced radiosensitivity of EC109 cells by inhibition of HDAC1 expression. Medical Oncology 29:1, pages 340-348.
Crossref
Crossref
Razmik Mirzayans, Bonnie Andrais, April Scott & David Murray. (2012) New Insights into p53 Signaling and Cancer Cell Response to DNA Damage: Implications for Cancer Therapy. Journal of Biomedicine and Biotechnology 2012, pages 1-16.
Crossref
Crossref
Ines Zidi & Nidhal Ben Amor. (2011) HLA-G regulators in cancer medicine: an outline of key requirements. Tumor Biology 32:6, pages 1071-1086.
Crossref
Crossref
Yuhui Li, Hongxia Zhou, Enming Xing, Meera Dassarath, Jinghua Ren, Xiaorong Dong, Hongli Liu, Kunyu Yang & Gang Wu. (2011) Contribution of decreased expression of Ku70 to enhanced radiosensitivity by sodium butyrate in glioblastoma cell line (U251). Journal of Huazhong University of Science and Technology [Medical Sciences] 31:3, pages 359-364.
Crossref
Crossref
Xufeng Chen, Jeffrey Y.C. Wong, Patty Wong & Eric H. Radany. (2011) Low-Dose Valproic Acid Enhances Radiosensitivity of Prostate Cancer through Acetylated p53-Dependent Modulation of Mitochondrial Membrane Potential and Apoptosis. Molecular Cancer Research 9:4, pages 448-461.
Crossref
Crossref
Claudia P. Miller, Melissa M. Singh, Nilsa Rivera-Del Valle, Christa A. Manton & Joya Chandra. (2011) Therapeutic Strategies to Enhance the Anticancer Efficacy of Histone Deacetylase Inhibitors. Journal of Biomedicine and Biotechnology 2011, pages 1-17.
Crossref
Crossref
Anthony M. Brade & Zishan Allibhai. 2011. Advances in Radiation Oncology in Lung Cancer. Advances in Radiation Oncology in Lung Cancer
213
222
.
Claudia Blattmann, Susanne Oertel, Volker Ehemann, Markus Thiemann, Peter E. Huber, Marc Bischof, Olaf Witt, Hedwig E. Deubzer, Andreas E. Kulozik, Jürgen Debus & Klaus-J. Weber. (2010) Enhancement of Radiation Response in Osteosarcoma and Rhabomyosarcoma Cell Lines by Histone Deacetylase Inhibition. International Journal of Radiation Oncology*Biology*Physics 78:1, pages 237-245.
Crossref
Crossref